ISSN: 1449-2288International Journal of Biological Sciences
Global reach, higher impact
Int J Biol Sci 2021; 17(15):4092. doi:10.7150/ijbs.66938 This issue Cite
Retraction
Retraction: Andrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma
Citation:
International Journal of Biological Sciences. Retraction: Andrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma. Int J Biol Sci 2021; 17(15):4092. doi:10.7150/ijbs.66938. https://www.ijbs.com/v17p4092.htm
Other stylesRetracted-article in Int J Biol Sci, Volume 10, 404
This article (Andrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma. Qian-Qian Zhang, Yi Ding, Yan Lei, et al. Int J Biol Sci 2014; 10(4): 404-414) has been retracted due to concerns on multiple image duplications as identified by PubPeer users. This raises concerns about the integrity of the data presented in the paper.
Published 2021-10-8
Citation styles
APA
International Journal of Biological Sciences (2021). Retraction: Andrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma. International Journal of Biological Sciences, 17(15), 4092. https://doi.org/10.7150/ijbs.66938.
ACS
International Journal of Biological Sciences Retraction: Andrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma. Int. J. Biol. Sci. 2021, 17 (15), 4092. DOI: 10.7150/ijbs.66938.
NLM
International Journal of Biological Sciences. Retraction: Andrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma. Int J Biol Sci 2021; 17(15):4092. doi:10.7150/ijbs.66938. https://www.ijbs.com/v17p4092.htm
CSE
International Journal of Biological Sciences. 2021. Retraction: Andrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma. Int J Biol Sci. 17(15):4092.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.